Potassium

Potassium

SCHEMBL18260591

CCCCC(CC)COCC(CC)CCCC.[K]

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.64
ALDH1A1 P00352 7/20 0.58
L3MBTL1 Q9Y468 1/20 0.57
TDP1 Q9NUW8 2/20 0.52
TSHR P16473 4/20 0.52
ATM Q13315 1/20 0.52
MMP9 P14780 1/20 0.47
MMP8 P22894 1/20 0.47
MMP14 P50281 1/20 0.47
CA2 P00918 4/20 0.44
RECQL P46063 1/20 0.42
LMNA P02545 2/20 0.40
MAPK1 P28482 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CA1 P00915 1/20 0.39
PRSS1 P07477 1/20 0.39
PRSS2 P07478 1/20 0.39
PRSS3 P35030 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL80432 0.97 CYP3A4 (0.67) CYP3A4ALDH1A1L3MBTL1TDP1TSHR
SCHEMBL288653 0.95 CYP3A4 (0.64) CYP3A4ALDH1A1L3MBTL1TDP1TSHR
Calcium SCHEMBL10786160 0.95 CYP3A4 (0.64) CYP3A4ALDH1A1L3MBTL1TDP1TSHR
SCHEMBL1230777 0.95 CYP3A4 (0.64) CYP3A4ALDH1A1L3MBTL1TDP1TSHR
SCHEMBL18835723 0.95 CYP3A4 (0.64) CYP3A4ALDH1A1L3MBTL1TDP1TSHR
SCHEMBL23087841 0.95 CYP3A4 (0.64) CYP3A4ALDH1A1L3MBTL1TDP1TSHR
Magnesium SCHEMBL10786879 0.95 CYP3A4 (0.64) CYP3A4ALDH1A1L3MBTL1TDP1TSHR
Barium SCHEMBL10790747 0.95 CYP3A4 (0.64) CYP3A4ALDH1A1L3MBTL1TDP1TSHR
SCHEMBL8281040 0.95 CYP3A4 (0.64) CYP3A4ALDH1A1L3MBTL1TDP1TSHR
SCHEMBL10842882 0.95 CYP3A4 (0.64) CYP3A4ALDH1A1L3MBTL1TDP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3303350-B1 BASE-CATALYZED SILYLATION OF TERMINAL OLEFINIC C-H BONDS CALIFORNIA INST OF TECHN (US) 2023-11-22 EP disclosed
EP-3909959-A1 BASE-CATALYZED SILYLATION OF TERMINAL OLEFINIC C-H BONDS California Institute of Technology (US) 2021-11-17 EP disclosed
US-10059726-B2 Base-catalyzed silylation of terminal olefinic C—H bonds CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2018-08-28 US disclosed
EP-3303350-A1 BASE-CATALYZED SILYLATION OF TERMINAL OLEFINIC C-H BONDS California Institute of Technology (US) 2018-04-11 EP disclosed
WO-2016196250-A1 BASE-CATALYZED SILYLATION OF TERMINAL OLEFINIC C-H BONDS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2016-12-08 WO disclosed
US-20160347776-A1 BASE-CATALYZED SILYLATION OF TERMINAL OLEFINIC C-H BONDS CALIFORNIA INSTITUTE OF TECHNOLOGY 2016-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160347776-A1 BASE-CATALYZED SILYLATION OF TERMINAL OLEFINIC C-H BONDS DOHH, OSBP, HRH3 CYP3A4 2252/4885ALDH1A1 2225/4885L3MBTL1 762/4885
US-10059726-B2 Base-catalyzed silylation of terminal olefinic C—H bonds DOHH, OSBP, OSBP2 CYP3A4 2228/4885ALDH1A1 2309/4885L3MBTL1 785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.